Kimberly Elizabeth Fultz

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Prekallikrein-modulating compositions and methods of use thereof
- Patent number 12,042,509
- Issue date Jul 23, 2024
- ADARx Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer using TOR kinase inhibitor combination...
- Patent number 10,004,735
- Issue date Jun 26, 2018
- Signal Pharmaceuticals, LLC
- Kimberly Elizabeth Fultz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer using TOR kinase inhibitor combination...
- Patent number 9,737,535
- Issue date Aug 22, 2017
- Signal Pharmaceuticals, LLC
- Kimberly Elizabeth Fultz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...
- Patent number 9,557,338
- Issue date Jan 31, 2017
- Signal Pharmaceuticals, LLC
- Weiming Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...
- Patent number 9,155,736
- Issue date Oct 13, 2015
- Signal Pharmaceuticals, LLC
- Weiming Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,507,492
- Issue date Aug 13, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,492,381
- Issue date Jul 23, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...
- Patent number 8,110,578
- Issue date Feb 7, 2012
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANGIOTENSINOGEN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20240041913
- Publication date Feb 8, 2024
- ADARx Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEMENT FACTOR B-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20240043836
- Publication date Feb 8, 2024
- ADARx Pharmaceuticals, Inc.
- Zhen Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADAR DEPENDENT EDITING COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20230272391
- Publication date Aug 31, 2023
- ADARx Pharmaceutical, Inc.
- Zhen Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20230158059
- Publication date May 25, 2023
- ADARx Pharmaceuticals, Inc.
- Zhen Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20230119470
- Publication date Apr 20, 2023
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...
- Publication number 20170312278
- Publication date Nov 2, 2017
- Signal Pharmaceuticals, LLC.
- Kimberly Elizabeth FULTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20160024101
- Publication date Jan 28, 2016
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...
- Publication number 20150362505
- Publication date Dec 17, 2015
- Signal Pharmaceuticals, LLC.
- Weiming Xu
- G01 - MEASURING TESTING
Information Patent Application
METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...
- Publication number 20150297590
- Publication date Oct 22, 2015
- Signal Pharmaceuticals, LLC.
- Kimberly Elizabeth FULTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH TOR KINASE INHIBITORS
- Publication number 20140113904
- Publication date Apr 24, 2014
- Signal Pharmaceuticals, LLC.
- Deborah Mortensen
- G01 - MEASURING TESTING
Information Patent Application
INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...
- Publication number 20140113905
- Publication date Apr 24, 2014
- Signal Pharmaceuticals, LLC.
- Weiming Xu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20130289271
- Publication date Oct 31, 2013
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120071658
- Publication date Mar 22, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120059164
- Publication date Mar 8, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...
- Publication number 20100216781
- Publication date Aug 26, 2010
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY

Kimberly Elizabeth Fultz

Person

Patents Grantslast 30 patents

Prekallikrein-modulating compositions and methods of use thereof

Methods for treating cancer using TOR kinase inhibitor combination...

Methods for treating cancer using TOR kinase inhibitor combination...

Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...

Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...

Patents Applicationslast 30 patents

ANGIOTENSINOGEN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

COMPLEMENT FACTOR B-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

ADAR DEPENDENT EDITING COMPOSITIONS AND METHODS OF USE THEREOF

PREKALLIKREIN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...

METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION...

TREATMENT OF CANCER WITH TOR KINASE INHIBITORS

INHIBITION OF PHOSPHORYLATION OF PRAS40, GSK3-BETA OR P70S6K1 AS A...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...